NPI: 1245221050 · MURRIETA, CA 92562 · General Acute Care Hospital · NPI assigned 11/01/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 11/01/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 272,112 | $7.42M |
| 2019 | 307,351 | $8.85M |
| 2020 | 212,684 | $6.70M |
| 2021 | 235,980 | $8.07M |
| 2022 | 259,439 | $9.51M |
| 2023 | 275,684 | $10.68M |
| 2024 | 245,746 | $10.72M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 160,306 | 139,682 | $8.72M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 90,972 | 80,903 | $5.42M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 13,657 | 13,164 | $4.44M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 33,050 | 30,543 | $2.99M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4,428 | 4,339 | $2.31M |
| 70450 | Computed tomography, head or brain; without contrast material | 19,210 | 18,428 | $2.21M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 12,201 | 11,733 | $2.01M |
| 93975 | 5,977 | 5,756 | $1.93M | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 47,202 | 42,554 | $1.44M |
| 96375 | Therapeutic injection; each additional sequential IV push | 23,824 | 21,728 | $1.41M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 32,657 | 29,964 | $1.35M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5,833 | 5,596 | $1.13M |
| 72125 | Computed tomography, cervical spine; without contrast material | 6,739 | 6,464 | $1.08M |
| 80053 | Comprehensive metabolic panel | 86,487 | 78,303 | $1.05M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12,957 | 11,584 | $1.05M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9,484 | 8,738 | $1.02M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,459 | 3,366 | $949K |
| L8699 | Prosthetic implant, not otherwise specified | 531 | 427 | $939K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,672 | 6,176 | $810K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 88,806 | 80,159 | $754K |
| 99499 | 8,675 | 7,829 | $751K | |
| 71045 | Radiologic examination, chest; single view | 41,414 | 39,111 | $706K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 9,010 | 8,476 | $653K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 17,630 | 16,934 | $593K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 6,343 | 6,118 | $564K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,655 | 5,269 | $499K |
| 93971 | 3,545 | 3,435 | $483K | |
| 76801 | 5,531 | 4,698 | $476K | |
| 70496 | 1,652 | 1,609 | $424K | |
| 84484 | 37,317 | 25,309 | $418K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 9,879 | 9,291 | $371K |
| 70498 | 1,726 | 1,673 | $367K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5,227 | 5,159 | $356K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 3,864 | 3,391 | $343K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,542 | 3,462 | $333K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,029 | 1,943 | $327K |
| 70486 | 2,090 | 2,032 | $285K | |
| 71046 | Radiologic examination, chest; 2 views | 9,741 | 9,321 | $284K |
| 83690 | 36,310 | 33,790 | $281K | |
| 93970 | 1,115 | 1,083 | $278K | |
| Z7502 | 7,309 | 7,241 | $276K | |
| 72131 | 1,746 | 1,697 | $271K | |
| 76830 | Ultrasound, transvaginal | 3,296 | 3,192 | $260K |
| 83880 | 7,827 | 7,470 | $255K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 674 | 553 | $235K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,915 | 3,835 | $229K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18,715 | 18,051 | $224K |
| 59025 | Fetal non-stress test | 10,397 | 7,520 | $222K |
| J3490 | Unclassified drugs | 82,358 | 44,316 | $209K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,461 | 4,340 | $198K |
| 0762 | 961 | 877 | $195K | |
| 81003 | 70,226 | 61,753 | $194K | |
| 84443 | Thyroid stimulating hormone (TSH) | 10,002 | 9,678 | $182K |
| 81025 | 33,347 | 31,166 | $173K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,879 | 1,837 | $173K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 7,743 | 7,229 | $170K |
| 99070 | 91,721 | 52,519 | $150K | |
| 84702 | 8,519 | 6,952 | $149K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,311 | 1,236 | $145K |
| 80048 | Basic metabolic panel (calcium, ionized) | 15,717 | 14,686 | $144K |
| 73630 | 4,990 | 4,872 | $143K | |
| 74174 | 365 | 358 | $139K | |
| 73610 | 4,516 | 4,395 | $137K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 15,247 | 14,335 | $134K |
| 73130 | 4,387 | 4,257 | $133K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,531 | 1,346 | $131K |
| 85610 | 30,595 | 28,669 | $130K | |
| 85730 | 20,009 | 18,946 | $126K | |
| 83735 | 18,151 | 16,661 | $126K | |
| 84703 | 14,048 | 13,410 | $121K | |
| 90715 | 3,512 | 3,461 | $120K | |
| 72100 | 3,424 | 3,356 | $116K | |
| 85027 | 16,455 | 15,485 | $116K | |
| 73030 | 3,871 | 3,715 | $113K | |
| 87040 | 9,133 | 5,502 | $103K | |
| 73564 | 3,067 | 2,985 | $99K | |
| 0710 | 2,002 | 1,797 | $94K | |
| 73110 | 3,050 | 2,972 | $94K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,454 | 2,355 | $93K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,934 | 1,795 | $92K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,441 | 2,348 | $88K |
| 84439 | 8,792 | 8,528 | $86K | |
| 83605 | 7,480 | 6,589 | $82K | |
| 74018 | 2,995 | 2,865 | $81K | |
| 81001 | 22,686 | 21,477 | $81K | |
| 76870 | 1,247 | 1,190 | $81K | |
| 74022 | 1,698 | 1,623 | $75K | |
| 73080 | 2,339 | 2,284 | $72K | |
| 99221 | 385 | 383 | $72K | |
| 71250 | 524 | 506 | $71K | |
| 85379 | 5,993 | 5,799 | $69K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,736 | 1,675 | $65K |
| 72040 | 2,185 | 2,136 | $65K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 31,166 | 29,237 | $65K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 14,228 | 13,615 | $62K |
| 73562 | 2,206 | 2,168 | $61K | |
| 36415 | Collection of venous blood by venipuncture | 21,598 | 18,166 | $59K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 249 | 243 | $59K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 344 | 326 | $58K |
| 73590 | 2,380 | 2,301 | $58K | |
| 0353U | 757 | 751 | $58K | |
| 73090 | 2,272 | 2,213 | $56K | |
| 94644 | 1,710 | 1,613 | $55K | |
| 72128 | 364 | 348 | $54K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 783 | 709 | $54K |
| 87186 | 5,750 | 5,225 | $53K | |
| 87077 | 6,027 | 5,349 | $50K | |
| 12011 | 1,576 | 1,547 | $50K | |
| 73502 | 1,214 | 1,184 | $48K | |
| 12001 | 1,942 | 1,895 | $46K | |
| 87276 | 4,382 | 4,087 | $45K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 23,827 | 22,156 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 673 | 473 | $43K |
| 0250 | 7,914 | 5,009 | $42K | |
| 70491 | 191 | 184 | $41K | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 388 | 383 | $41K |
| 76775 | 674 | 660 | $40K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 502 | 297 | $40K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1,153 | 973 | $40K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 8,740 | 7,816 | $36K |
| 87631 | 503 | 494 | $36K | |
| 72072 | 990 | 973 | $35K | |
| 82962 | 9,062 | 5,692 | $34K | |
| 74019 | 970 | 934 | $34K | |
| 86901 | 9,446 | 8,870 | $34K | |
| 72170 | 1,348 | 1,299 | $32K | |
| 87275 | 4,387 | 4,089 | $32K | |
| 82550 | 4,517 | 4,193 | $32K | |
| 71101 | 871 | 853 | $31K | |
| 86900 | 9,459 | 8,869 | $31K | |
| 87070 | 2,962 | 2,853 | $29K | |
| 86850 | 4,889 | 4,593 | $29K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 8,017 | 7,510 | $26K |
| 82803 | 1,563 | 1,387 | $25K | |
| G0378 | Hospital observation service, per hour | 326 | 324 | $25K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 533 | 514 | $25K |
| 86141 | 1,698 | 1,605 | $24K | |
| 0272 | 194 | 188 | $24K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 5,538 | 4,722 | $24K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,938 | 3,719 | $24K |
| 96367 | 441 | 423 | $23K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,595 | 3,510 | $22K |
| 0510 | 857 | 545 | $22K | |
| 29125 | 1,754 | 1,697 | $21K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,322 | 3,167 | $21K |
| 86923 | 240 | 217 | $20K | |
| 10060 | 784 | 747 | $19K | |
| 73140 | 920 | 895 | $19K | |
| 86140 | 3,185 | 3,057 | $19K | |
| 73552 | 563 | 543 | $18K | |
| 0270 | 7,449 | 5,659 | $18K | |
| 0360 | 190 | 74 | $17K | |
| 31720 | 653 | 570 | $16K | |
| 12002 | 594 | 579 | $16K | |
| 51701 | 883 | 832 | $16K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 479 | 453 | $15K |
| 87430 | 1,262 | 1,220 | $14K | |
| J2704 | Injection, propofol, 10 mg | 3,844 | 3,655 | $14K |
| 82553 | 1,143 | 991 | $13K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 477 | 458 | $13K |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,746 | 3,404 | $13K |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 417 | 415 | $12K |
| 82010 | 1,464 | 1,357 | $12K | |
| Z7610 | 1,218 | 733 | $12K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 36 | 36 | $12K |
| 93976 | 45 | 45 | $12K | |
| 29515 | 861 | 828 | $11K | |
| 87210 | 2,168 | 2,111 | $11K | |
| 99199 | Unlisted special service, procedure or report | 230 | 210 | $11K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 146 | 145 | $10K |
| 87205 | 2,362 | 2,157 | $10K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 5,013 | 4,793 | $10K |
| 73060 | 412 | 407 | $10K | |
| 87641 | 266 | 260 | $10K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 151 | 149 | $10K |
| 96376 | 910 | 679 | $9K | |
| 86677 | 503 | 480 | $9K | |
| 71010 | 377 | 368 | $9K | |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 425 | 294 | $9K |
| 84100 | 1,794 | 1,714 | $9K | |
| 87081 | 1,102 | 1,063 | $9K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 5,195 | 4,949 | $9K |
| 82375 | 556 | 510 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,399 | 3,112 | $8K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,554 | 4,317 | $7K |
| 71020 | 176 | 172 | $7K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,888 | 1,730 | $7K |
| J2060 | Injection, lorazepam, 2 mg | 3,780 | 3,417 | $7K |
| 36000 | 963 | 938 | $7K | |
| 85652 | 2,207 | 2,121 | $7K | |
| 84550 | 1,110 | 1,026 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,548 | 3,437 | $6K |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 120 | 103 | $6K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 71 | 27 | $5K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 293 | 291 | $5K |
| 82810 | 513 | 476 | $5K | |
| 87420 | 765 | 695 | $5K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 323 | 296 | $5K |
| 83050 | 558 | 517 | $5K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 55 | 50 | $5K |
| 86308 | 794 | 780 | $5K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 914 | 893 | $5K |
| 80061 | Lipid panel | 464 | 432 | $4K |
| S0077 | Injection, clindamycin phosphate, 300 mg | 430 | 424 | $4K |
| 72141 | 12 | 12 | $4K | |
| 70360 | 213 | 200 | $4K | |
| 82140 | 266 | 252 | $4K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 300 | 291 | $4K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 578 | 552 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 24 | 24 | $3K |
| 74021 | 89 | 86 | $3K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,075 | 987 | $3K |
| 99217 | 110 | 96 | $3K | |
| 97597 | 69 | 39 | $3K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,751 | 3,609 | $3K |
| 85384 | 279 | 265 | $3K | |
| 29105 | 217 | 211 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 14 | 12 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 743 | 641 | $3K |
| 88307 | 65 | 27 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 490 | 448 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 309 | 296 | $2K |
| J1630 | Injection, haloperidol, up to 5 mg | 1,031 | 912 | $2K |
| 82570 | 349 | 315 | $2K | |
| 84132 | 153 | 147 | $2K | |
| 84145 | 89 | 83 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 994 | 629 | $2K |
| 88304 | 141 | 129 | $2K | |
| 83986 | 375 | 349 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | 1,748 | 1,635 | $2K |
| 88342 | 54 | 42 | $2K | |
| 82150 | 202 | 196 | $2K | |
| 51702 | 124 | 112 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 217 | 190 | $1K |
| 87486 | 36 | 36 | $1K | |
| 87581 | 36 | 36 | $1K | |
| C9113 | Injection, pantoprazole sodium, per vial | 256 | 237 | $1K |
| 84156 | 329 | 298 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 107 | 84 | $1K |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 65 | 64 | $1K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 537 | 498 | $1K |
| J8540 | Dexamethasone, oral, 0.25 mg | 497 | 482 | $1K |
| 73000 | 51 | 51 | $1K | |
| 82272 | 563 | 540 | $1K | |
| 72070 | 44 | 44 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 695 | 683 | $1K |
| 82731 | 12 | 12 | $860.82 | |
| 87320 | 58 | 57 | $856.52 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 299 | 250 | $836.74 |
| 74000 | 31 | 29 | $824.91 | |
| 76010 | 26 | 26 | $723.52 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 73 | 71 | $692.02 |
| 87045 | 67 | 67 | $656.27 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 84 | 71 | $637.13 |
| 82728 | 44 | 42 | $629.53 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 542 | 485 | $593.48 |
| 36430 | 30 | 24 | $515.49 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 31 | 24 | $513.75 |
| 83721 | 54 | 53 | $505.46 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 62 | 42 | $462.55 |
| L3999 | Upper limb orthosis, not otherwise specified | 157 | 139 | $435.66 |
| 86703 | 26 | 26 | $433.30 | |
| Q3014 | Telehealth originating site facility fee | 12 | 12 | $424.48 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 14 | 13 | $396.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 47 | 31 | $374.86 |
| 81002 | 120 | 115 | $373.17 | |
| A9270 | Non-covered item or service | 3,366 | 1,294 | $366.05 |
| 84450 | 61 | 53 | $357.84 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 162 | 162 | $330.48 |
| 80076 | 41 | 41 | $321.79 | |
| 83615 | 42 | 42 | $314.30 | |
| 86780 | 25 | 25 | $286.18 | |
| 87147 | 52 | 39 | $284.06 | |
| 84460 | 46 | 40 | $272.63 | |
| 73660 | 13 | 13 | $222.86 | |
| 82248 | 28 | 26 | $218.08 | |
| 82565 | 29 | 27 | $179.17 | |
| 85007 | 45 | 43 | $143.53 | |
| 90686 | 14 | 14 | $137.67 | |
| 84520 | 28 | 26 | $129.33 | |
| 82247 | 12 | 12 | $116.53 | |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 194 | 95 | $99.21 |
| J3480 | Injection, potassium chloride, per 2 meq | 58 | 42 | $83.95 |
| J3370 | Injection, vancomycin hcl, 500 mg | 12 | 12 | $77.12 |
| J7510 | Prednisolone oral, per 5 mg | 199 | 189 | $60.87 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 21 | 20 | $50.00 |
| 82040 | 12 | 12 | $47.79 | |
| 85014 | 14 | 13 | $42.45 | |
| 85018 | 14 | 13 | $42.45 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 58 | 53 | $22.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 29 | 28 | $17.10 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 44 | 42 | $7.42 |